Chuqing Cao

This collaborator is listed from publication metadata. Full profile details are maintained only for lab members.

Related Publications

† First or co-first author, * Corresponding or co-corresponding author, bold names are lab members

Xia Li†, Shu-Ting YANG†, Chuqing Cao, Xiang Yan, Lei Zheng, Lanbo Zheng, Jiarui Da, Xiaohan Tang, Linong Ji, Xilin Yang*, Zhiguang Zhou* (2020). Journal Article Validation of the Swedish diabetes re-grouping scheme in adult-onset diabetes in China. The Journal of Clinical Endocrinology & Metabolism.
PMID DOI
Chuqing Cao†, Shu-Ting YANG, Zhiguang Zhou* (2020). Journal Article GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials. Endocrine.
PMID DOI
Shu-Ting YANG†, Chuqing Cao, Zhiguo Xie, Zhiguang Zhou* (2020). Journal Article Analysis of potential hub genes involved in the pathogenesis of Chinese type 1 diabetic patients. Annals of Translational Medicine.
PMID DOI
Chuqing Cao†, Shu-Ting YANG, Zhiguang Zhou* (2020). Journal Article The potential application of Cordyceps in metabolic-related disorders. Phytotherapy Research.
Shu-Ting YANG†, Chuqing Cao, Tuo Deng, Zhiguang Zhou* (2020). Journal Article Obesity-related glomerulopathy: a latent change in obesity requiring more attention. Kidney and Blood Pressure Research.
Chuqing Cao†, Shu-Ting YANG, Zhiguang Zhou* (2019). Journal Article GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials. Endocrine.
PMID DOI